On October 20, Talaris announced the latest progress of the Phase III FREEDOM-1 study of its investigational allogeneic cell therapy FCR001 for inhibiting acute immune
On October 21, the FDA’s official website showed that AstraZeneca’s anti-CTLA-4 monoclonal antibody tremelimumab (temslimumab) was approved by the FDA for listing, and the approved
The results of a new study show that a bispecific antibody drug, Ubamatamab, has shown good results in ovarian cancer patients and has a good
On October 20, Immunic announced that its Phase Ib clinical trial of its RORγt inverse agonist IMU-935 in the treatment of psoriasis failed to meet
On October 19, GSK announced that the ZOSTER-049 extension study yielded positive interim results: Shingrix provides at least 10 years of shingles protection in adults
On October 20, Roche and HookipaPharma entered into a strategic collaboration and licensing agreement to co-develop HB-700 and a second undisclosed novel arenavirus immunotherapy for
In order to carry out anti-cancer metastasis, it is necessary to understand the metastasis route of cancer cells, the process of metastasis and the steps
On October 18, Eli Lilly announced a definitive agreement to acquire Akouos. Under the terms of the deal, Eli Lilly will acquire all outstanding shares
Given the complex roles of macrophages, both good and evil, in various biological contexts, researchers have been exploring their abundance and function. This guide outlines
On October 17, Milestone Pharmaceuticals announced positive data from the Phase III RAPID study of the inhaled calcium channel blocker Etripamil in the treatment of
On October 14, a study titled “Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast
Kras is a murine sarcoma virus oncogene. There are three genes in the ras gene family associated with human tumors—H-ras, K-ras, and N-ras, which are
